Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001654787> ?p ?o ?g. }
- W2001654787 endingPage "52" @default.
- W2001654787 startingPage "42" @default.
- W2001654787 abstract "Membrane rafts and caveolae are specialized microdomains of the cell membrane that form physical platforms for compartmentalization of signalling molecules. Here, we intended to gain insight into the consequences of caveolar localization in G protein-coupled receptor function. We analysed beta(2)-adrenoceptor signalling in purified CRLDF (caveolin-rich low density fractions) of beta(2)-adrenoceptor-overexpressing HEK-293 cells. beta(2)-adrenoceptor and Gs immunoreactivities and forskolin-stimulated adenylate cyclase activity were all detected in CRLDF obtained by the conventional raft purification method that uses Triton X-100 solubilization. However, Triton X-100 caused a complete loss of the functional coupling between beta(2)-adrenoceptor, Gs and adenylate cyclase. Therefore, we developed an optimized purification method based on n-octyl-beta-d-glucopyranoside solubilization, where the functional properties of beta(2)-adrenoceptor, Gs and adenylate cyclase were preserved in the CRLDF. Using this method, we showed that isoproterenol-stimulated adenylate cyclase activity was similar in CRLDF and bulk membrane preparations of HEK-293 cells that overexpress beta(2)-adrenoceptor or beta(2)-adrenoceptor-Gs fusion. Accordingly, treatment of cells with methyl-beta-cyclodextrin, a caveola-disrupting agent, did not affect beta(2)-adrenoceptor-induced cAMP response. Likewise, these responses were insensitive to caveolin 1 and 2 overexpression. On the other hand, methyl-beta-cyclodextrin treatment did decrease beta(2)-adrenoceptor-induced ERK phosphorylation. However, the latter effect of methyl-beta-cyclodextrin could be attributed to a non-specific effect rather than its ability to disrupt membrane microdomains. We showed that localization in the raft microdomains did not affect the signalling efficiency of beta(2)-adrenoceptor-Gs-adenylate cyclase pathway, and that methyl-beta-cyclodextrin may inhibit signalling by directly affecting the signalling system independently of its caveola-disrupting property." @default.
- W2001654787 created "2016-06-24" @default.
- W2001654787 creator A5018729706 @default.
- W2001654787 creator A5023264565 @default.
- W2001654787 creator A5035521224 @default.
- W2001654787 creator A5051040995 @default.
- W2001654787 creator A5080797625 @default.
- W2001654787 date "2010-03-01" @default.
- W2001654787 modified "2023-10-02" @default.
- W2001654787 title "β2-Adrenoceptor, Gs and adenylate cyclase coupling in purified detergent-resistant, low density membrane fractions" @default.
- W2001654787 cites W1534945206 @default.
- W2001654787 cites W1564861448 @default.
- W2001654787 cites W1704045495 @default.
- W2001654787 cites W1934687632 @default.
- W2001654787 cites W1966949741 @default.
- W2001654787 cites W1978281474 @default.
- W2001654787 cites W1982442386 @default.
- W2001654787 cites W1982482091 @default.
- W2001654787 cites W1993357003 @default.
- W2001654787 cites W2007479992 @default.
- W2001654787 cites W2008374286 @default.
- W2001654787 cites W2008824442 @default.
- W2001654787 cites W2022992564 @default.
- W2001654787 cites W2032190558 @default.
- W2001654787 cites W2035684590 @default.
- W2001654787 cites W2039172223 @default.
- W2001654787 cites W2046753575 @default.
- W2001654787 cites W2048327066 @default.
- W2001654787 cites W2048777704 @default.
- W2001654787 cites W2053204073 @default.
- W2001654787 cites W2053642248 @default.
- W2001654787 cites W2059939486 @default.
- W2001654787 cites W2063976599 @default.
- W2001654787 cites W2074990110 @default.
- W2001654787 cites W2082179247 @default.
- W2001654787 cites W2086652137 @default.
- W2001654787 cites W2096864415 @default.
- W2001654787 cites W2106629432 @default.
- W2001654787 cites W2110979251 @default.
- W2001654787 cites W2114481572 @default.
- W2001654787 cites W2116309149 @default.
- W2001654787 cites W2128963767 @default.
- W2001654787 cites W2133388060 @default.
- W2001654787 cites W2182502499 @default.
- W2001654787 cites W82875452 @default.
- W2001654787 doi "https://doi.org/10.1016/j.ejphar.2009.12.035" @default.
- W2001654787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20045406" @default.
- W2001654787 hasPublicationYear "2010" @default.
- W2001654787 type Work @default.
- W2001654787 sameAs 2001654787 @default.
- W2001654787 citedByCount "7" @default.
- W2001654787 countsByYear W20016547872012 @default.
- W2001654787 countsByYear W20016547872013 @default.
- W2001654787 countsByYear W20016547872016 @default.
- W2001654787 countsByYear W20016547872018 @default.
- W2001654787 countsByYear W20016547872019 @default.
- W2001654787 countsByYear W20016547872023 @default.
- W2001654787 crossrefType "journal-article" @default.
- W2001654787 hasAuthorship W2001654787A5018729706 @default.
- W2001654787 hasAuthorship W2001654787A5023264565 @default.
- W2001654787 hasAuthorship W2001654787A5035521224 @default.
- W2001654787 hasAuthorship W2001654787A5051040995 @default.
- W2001654787 hasAuthorship W2001654787A5080797625 @default.
- W2001654787 hasConcept C11960822 @default.
- W2001654787 hasConcept C12554922 @default.
- W2001654787 hasConcept C135285700 @default.
- W2001654787 hasConcept C170493617 @default.
- W2001654787 hasConcept C174510640 @default.
- W2001654787 hasConcept C180526460 @default.
- W2001654787 hasConcept C185592680 @default.
- W2001654787 hasConcept C199360897 @default.
- W2001654787 hasConcept C2776174256 @default.
- W2001654787 hasConcept C2779276759 @default.
- W2001654787 hasConcept C2779403975 @default.
- W2001654787 hasConcept C2780069284 @default.
- W2001654787 hasConcept C41008148 @default.
- W2001654787 hasConcept C41625074 @default.
- W2001654787 hasConcept C49866891 @default.
- W2001654787 hasConcept C55493867 @default.
- W2001654787 hasConcept C78976303 @default.
- W2001654787 hasConcept C86803240 @default.
- W2001654787 hasConcept C95444343 @default.
- W2001654787 hasConceptScore W2001654787C11960822 @default.
- W2001654787 hasConceptScore W2001654787C12554922 @default.
- W2001654787 hasConceptScore W2001654787C135285700 @default.
- W2001654787 hasConceptScore W2001654787C170493617 @default.
- W2001654787 hasConceptScore W2001654787C174510640 @default.
- W2001654787 hasConceptScore W2001654787C180526460 @default.
- W2001654787 hasConceptScore W2001654787C185592680 @default.
- W2001654787 hasConceptScore W2001654787C199360897 @default.
- W2001654787 hasConceptScore W2001654787C2776174256 @default.
- W2001654787 hasConceptScore W2001654787C2779276759 @default.
- W2001654787 hasConceptScore W2001654787C2779403975 @default.
- W2001654787 hasConceptScore W2001654787C2780069284 @default.
- W2001654787 hasConceptScore W2001654787C41008148 @default.
- W2001654787 hasConceptScore W2001654787C41625074 @default.
- W2001654787 hasConceptScore W2001654787C49866891 @default.
- W2001654787 hasConceptScore W2001654787C55493867 @default.